PCM
BIIB icon

Prelude Capital Management’s Biogen BIIB Stock Holding History

Prelude Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,700
Closed -$471K – 1190
2022
Q4 		$471K Hold
1,700
– – 0.02% 595
2022
Q3 		$454K Sell
1,700
-600
-26% -$127K 0.02% 688
2022
Q2 		$469K Sell
2,300
-900
-28% -$184K 0.01% 847
2022
Q1 		$674K Buy
3,200
+1,600
+100% +$348K 0.02% 729
2021
Q4 		$384K Buy
1,600
+600
+60% +$154K 0.01% 1174
2021
Q3 		$283K Hold
1,000
– – 0.01% 1166
2021
Q2 		$294K Sell
1,000
-5,400
-84% -$1.64M 0.01% 1203
2021
Q1 		$1.79M Buy
6,400
+5,400
+540% +$1.46M 0.05% 382
2020
Q4 		$245K Buy
1,000
+800
+400% +$206K 0.01% 1013
2020
Q3 		$57K Buy
+200
New +$55.8K ﹤0.01% 1083
2020
Q2 		– Sell
-11,600
Closed -$3.67M – 1961
2020
Q1 		$3.67M Buy
11,600
+4,800
+71% +$1.46M 0.25% 47
2019
Q4 		$2.02M Buy
6,800
+400
+6% +$111K 0.08% 221
2019
Q3 		$1.49M Hold
6,400
– – 0.07% 241
2019
Q2 		$1.5M Sell
6,400
-1,100
-15% -$254K 0.07% 252
2019
Q1 		$1.77M Buy
+7,500
New +$2.36M 0.1% 208
2014
Q1 		– Sell
-700
Closed -$196K – 1861
2013
Q4 		$196K Buy
+700
New +$181K 0.03% 624

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Prelude Capital Management's BIIB Position: Q4 2024 in Review

Prelude Capital Management sold out of Biogen (BIIB) in Q4 2024, closing a stake of 2,400 shares — an estimated $465K sold.

Prelude Capital Management first reported a position in BIIB in Q2 2013 and held it in 38 quarters. The position peaked at $3.15M in Q1 2023. 874 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • Prelude Capital Management reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
  • Prelude Capital Management sold 2,400 Biogen shares in Q4 2024, an estimated $465K.
  • Prelude Capital Management first reported a position in Biogen in Q2 2013 and held it in 38 quarters.
  • Prelude Capital Management's Biogen position peaked at $3.15M in Q1 2023.
  • 874 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Prelude Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.